BioWorld Asia

July 2, 2003

View Archived Issues

Researchers Discover Gene With Implications In Ovarian Cancer

Karolinska Institute Establishes Fund For Early Stage Spinouts

G10 Paper Calls For Changes, Balance In EU Debate On Drugs

Cerep Cites Weak Economy, Dollar In Lowering Guidance

Irish Universities Join Venture To Develop Peptide Antibiotics

Meristem, Stallergenes Partner For Production Of Allergens

Amrad, Merck Enter Alliance Apparently Focused On Asthma

FDA Commissioner Spells Out Plans For Shoring Up Agency

U.S. Must Get Behind Stem Cell Research For Science To Take Off

Wilex Begins Clinical Testing Of Product For Biliary Cancers

Other News To Note

UK Government Initiates Broad, £50M Program In Area Of Genetics

LONDON - The UK government announced a £50 million (US$83 million) program over the next three years to expand the use of genetic testing in the National Health Service (NHS), with the aim of making the UK a leader in genetics-based health care. (BioWorld International) Read More

Zealand, Aventis Enter $100M Pact To Develop Diabetes Drug

Today's news in brief

BioWorld

BioWorld briefs for June 12, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 9, 2026

3D rendering of β2-Adrenergic receptor GPCR protein molecule embedded in lipid bilayer membrane.

Skape Bio unlocks GPCR targets with de novo-designed miniproteins

BioWorld

Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...

Pre-disease plasma signature may help redefine lung cancer risk

BioWorld

Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...

New 5-HT2C receptor agonists reported in Hansoh patent

BioWorld Science

Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...